Gilead Sciences, Inc v. Khaim

Court

District Court, E.D. New York (E.D.N.Y)
Official Court Website →

Assigned judge

Natasha C. Merle · 254 cases in index

Docket number

1:24-cv-04259

Cause

15:1125 Trademark Infringement (Lanham Act)
15 U.S.C. § 1125 — Trademark / unfair competition (Lanham Act)

Nature of suit

840 Trademark
Infringement or dilution of a trademark under the Lanham Act.

Jurisdiction

Federal Question

Jury demand

Both

Date filed

06/17/2024

2,968 Trademark cases in this court are indexed here.

Parties

• plaintiff · Gilead Sciences, Inc Pharmaceuticals & Biotechnology · 97 cases
• defendant · Khaim

About Trademark Lawsuits

Trademark lawsuits allege infringement or dilution of a brand name, logo, or other mark under the Lanham Act — typically claims that one party's use is likely to confuse consumers about the source of goods or services.

Frequently Asked Questions

What is Gilead Sciences, Inc v. Khaim?

Gilead Sciences, Inc v. Khaim is a federal trademark lawsuit filed on 06/17/2024 in the District Court, E.D. New York. The case is currently open in the federal court system. Trademark lawsuits allege infringement or dilution of a brand name, logo, or other mark under the Lanham Act — typically claims that one party's use is likely to confuse consumers about the source of goods or services.

What type of case is this?

It is classified as “Trademark” under the federal nature-of-suit system. Trademark lawsuits allege infringement or dilution of a brand name, logo, or other mark under the Lanham Act — typically claims that one party's use is likely to confuse consumers about the source of goods or services.

What court is the case in?

The case is in the District Court, E.D. New York, docket number 1:24-cv-04259.

When was the case filed?

Gilead Sciences, Inc v. Khaim was filed on 06/17/2024. The case is currently open.

What law is the case brought under?

The docket lists the cause as 15 U.S.C. § 1125 — Trademark / unfair competition (Lanham Act).